ArticleCancer science2019
Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial.
Yasuhiro Shimizu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled itcites it